Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03132012
Other study ID # 1208010685
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 22, 2017
Est. completion date February 27, 2018

Study information

Verified date June 2018
Source Yale University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a pilot randomized controlled trial of an Internet-based skin cancer prevention intervention as compared to a standard of care control in 80 non-Hispanic white females ages 20-30.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date February 27, 2018
Est. primary completion date February 27, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 30 Years
Eligibility Inclusion Criteria:

- Tanned indoors in past 12 months

- Able to communicate well in English

- Reliable Internet access

Exclusion Criteria:

- History of skin cancer (self-report)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Indoor tanning intervention
6 Web-based modules that focus on preventing skin cancer through sun protection and indoor tanning reduction using the Theory of Planned Behavior and Prospect Theory
Standard of care control
One website with content similar to those available in dermatology offices on skin cancer prevention

Locations

Country Name City State
United States Yale School of Public Health New Haven Connecticut

Sponsors (2)

Lead Sponsor Collaborator
Yale University American Cancer Society, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Intention to indoor tan in next year Indoor tanning intentions are measured on a scale that ranges from 1 (definitely do not intend to indoor tan) to 7 (definitely do intend to indoor tan). Baseline
Primary Intention to indoor tan in next year Indoor tanning intentions are measured on a scale that ranges from 1 (definitely do not intend to indoor tan) to 7 (definitely do intend to indoor tan). 12 Weeks First Follow-up
Primary Intention to indoor tan in next year Indoor tanning intentions are measured on a scale that ranges from 1 (definitely do not intend to indoor tan) to 7 (definitely do intend to indoor tan). 24 Weeks Second Follow-up
Primary Number of indoor tanning sessions in the previous 3 months Self-report measure of number of times indoor tanned, reported retrospectively for the preceding 3 months. 12 weeks preceding baseline
Primary Number of indoor tanning sessions in the previous 3 months Self-report measure of number of times indoor tanned, reported retrospectively for the preceding 3 months. baseline to 12 Weeks (First Follow-up)
Primary Number of indoor tanning sessions in the previous 3 months Self-report measure of number of times indoor tanned, reported retrospectively for the preceding 3 months. From 12 Weeks (first Follow-up) to 24 Weeks (Second Follow-up)
Secondary Intention to sunbathe outdoors in the next year Sunbathing intentions are measured on a scale that ranges from 1 (definitely do not intend to indoor tan) to 7 (definitely do intend to indoor tan). Baseline
Secondary Intention to sunbathe outdoors in the next year Sunbathing intentions are measured on a scale that ranges from 1 (definitely do not intend to indoor tan) to 7 (definitely do intend to indoor tan). 12 weeks First Follow-up
Secondary Intention to sunbathe outdoors in the next year Sunbathing intentions are measured on a scale that ranges from 1 (definitely do not intend to indoor tan) to 7 (definitely do intend to indoor tan). 24 weeks Second Follow-up
Secondary Number of outdoor sunbathing sessions in the previous 3 months Self-report measure of number of times sunbathed, reported retrospectively for the preceding 3 months. 12 weeks preceding baseline
Secondary Number of outdoor sunbathing sessions in the previous 3 months Self-report measure of number of times sunbathed, reported retrospectively for the preceding 3 months. baseline to 12 Weeks (First Follow-up)
Secondary Number of outdoor sunbathing sessions in the previous 3 months Self-report measure of number of times sunbathed, reported retrospectively for the preceding 3 months. From 12 Weeks (first Follow-up) to 24 Weeks (Second Follow-up)
See also
  Status Clinical Trial Phase
Completed NCT00027586 - Imatinib Mesylate in Treating Patients With Metastatic Melanoma Phase 2
Not yet recruiting NCT02230462 - Patient Satisfaction After Facial Reconstruction N/A
Terminated NCT02900248 - CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Completed NCT00224744 - Prospective and Randomized Study to Evaluate Interest of Ultracision Use in Inguinal Lymph Nodes Curage Phase 3
Terminated NCT00865878 - ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients Phase 2
Not yet recruiting NCT05359419 - Comparison of Two Modes of Photodynamic Therapy for the Treatment of Actinic Keratosis on the Upper Extremities Phase 4
Active, not recruiting NCT00001813 - Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
Completed NCT02046811 - Reducing Skin Cancer Risk in Childhood Cancer Survivors N/A
Completed NCT02147080 - A Tailored Internet Intervention to Reduce Skin Cancer Risk Behaviors Among Young Adults N/A
Completed NCT00007631 - Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer Phase 3
Completed NCT00847912 - CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial Phase 4
Recruiting NCT02836548 - HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma Phase 1/Phase 2
Completed NCT01482104 - New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC) N/A
Enrolling by invitation NCT04630886 - Use of Tranexamic Acid in Reduction of Post-Op Complications in Mohs Micrographic Surgery Early Phase 1
Completed NCT03012581 - Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types Phase 2
Withdrawn NCT02813902 - A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors Phase 1
Not yet recruiting NCT02408835 - Negative Pressure Wound Therapy in Groin Dissection N/A
Completed NCT00204789 - Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients Phase 2
Completed NCT02310503 - Spanish Registry of Mohs Surgery
Active, not recruiting NCT04267861 - M7824 Related Adverse Effects in Adults With Cancer